EP Patent

EP3639812A4 — Sparingly-soluble component solubilized micelle and solution containing same

Assigned to Teika Pharamaceutical Co Ltd · Expires 2021-03-17 · 5y expired

What this patent protects

Patent listed against fexofenadine-hydrochloride.

Drugs covered by this patent

fexofenadine-hydrochloride (FEXOFENADINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP3639812A4
Jurisdiction: EP
Classification: —
Expires: 2021-03-17
Drug substance claim: No
Drug product claim: No
Assignee: Teika Pharamaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.